Tariff risk, supply chain fragility, and national security concerns are driving PE capital into domestic manufacturers at accelerating rates.
The conversation around reshoring has shifted from aspiration to action. Driven by tariff uncertainty, supply chain disruptions that exposed the fragility of offshore dependence, and a growing bipartisan consensus on the strategic importance of domestic manufacturing, private equity firms are deploying capital into U.S.-based manufacturers at a pace not seen in over a decade.
For lower middle market manufacturers --- particularly those producing mission-critical components for aerospace, defense, medical devices, and industrial infrastructure --- the implications are profound.
Several structural tailwinds are converging. First, tariff policy continues to inject uncertainty into global supply chains. Whether tariffs rise, fall, or remain stable, the mere risk of change is enough to make procurement leaders rethink offshore sourcing strategies. Companies that once tolerated 12-week lead times from Asian suppliers are now willing to pay a premium for domestic production with 3-week lead times and full traceability.
Second, the CHIPS Act, the Inflation Reduction Act, and related federal programs have created substantial incentives for domestic manufacturing investment. These programs are not just subsidizing semiconductor fabrication --- they are catalyzing investment across the broader manufacturing ecosystem, from precision machining to specialty chemicals to electronic components.
Third, the defense industrial base is being actively strengthened. The Department of Defense has signaled that supply chain resilience is a national security priority, and that means more procurement dollars flowing to domestic manufacturers with the certifications, quality systems, and security clearances required to serve defense programs.
Private equity firms evaluating manufacturing targets in 2026 are focused on several key attributes. Proprietary processes or specifications that create switching costs are highly valued. A CNC machine shop that can produce to aerospace tolerances with AS9100 certification occupies a very different competitive position than a general job shop.
Buyer concentration risk is scrutinized carefully. Manufacturers with diversified customer bases across multiple end markets command higher multiples than those dependent on a single OEM relationship.
Operational improvement potential is central to the investment thesis. Many lower middle market manufacturers have underinvested in automation, ERP systems, and lean processes. PE firms see this as an opportunity: a business generating $3 million in EBITDA with 15% margins might generate $5 million in EBITDA at 20% margins after a targeted capital expenditure program and operational overhaul.
Manufacturing M&A multiples have expanded meaningfully for businesses with the right characteristics. Defense-adjacent and aerospace component manufacturers are trading at 8-10x EBITDA in many cases, a significant premium to historical norms. Even general industrial manufacturers with strong operational fundamentals are seeing multiples in the 6-8x range, reflecting the sector's favorable positioning.
The KKR sale of Novaria Group --- an aerospace parts supplier --- to Arcline Investment Management for approximately $2.2 billion illustrates that secondary transactions in this space are generating significant returns for initial investors. The same dynamics that drive these large transactions are present at the lower middle market level.
For owners of niche manufacturing businesses, preparation should focus on three areas. First, formalize your quality management systems. Buyers in this space place enormous weight on certifications, documented processes, and audit histories. Second, invest in the equipment and automation that will drive margin improvement --- but document the capital expenditure plan and projected ROI so a buyer can underwrite the remaining opportunity. Third, build a management team that extends beyond the owner. The single greatest risk factor in a manufacturing acquisition is founder dependence, and the businesses that command premium valuations are those where the team can operate and grow without the founder in the building.
The reshoring trend is not cyclical. It is a structural reorientation of American manufacturing, and lower middle market businesses are at its center.
